| #50 |
Youngjin Yoo |
Siemens Healthcare Limited |
2 |
| #50 |
Robert E. Tarjan |
Intertrust Technologies |
2 |
| #50 |
Marco Gruteser |
Rutgers, The State University Of New Jersey |
2 |
| #50 |
Renqiang Min |
Nec |
2 |
| #50 |
Iain Melvin |
Nec |
2 |
| #50 |
David J. Augeri |
Bristol-Myers Squibb |
2 |
| #50 |
Thomas D. Golobish |
Cytosorbents |
2 |
| #50 |
Biplob Debnath |
Nec |
2 |
| #50 |
Jaehoon Ji |
Purdue Research Foundation |
2 |
| #50 |
Wei Wang |
Bristol-Myers Squibb |
2 |
| #50 |
Bonnie L. Bassler |
Princeton University |
2 |
| #50 |
Michael Jaentsch |
Siemens Aktiengesellschaft |
2 |
| #50 |
Niraj K. Jha |
Princeton University |
2 |
| #50 |
Bin Zheng |
Scripps Research |
2 |
| #50 |
Xianyang CHEN |
Educational Testing Service |
2 |
| #50 |
Yishan Li |
Turning Point Therapeutics |
2 |
| #50 |
Nicholas Garibaldi |
Black & Decker |
2 |
| #50 |
Donald Strum |
Masco Corporation Of Indiana |
2 |
| #50 |
Fatih Yaman |
Nec |
2 |
| #50 |
Zheng Shi |
Fih (Hong Kong) Limited |
2 |
| #50 |
Yevgeny Raitses |
Princeton University |
2 |
| #50 |
Shinsuke Fujisawa |
Nec |
2 |
| #50 |
Wenjie Zhao |
AT&T |
2 |
| #50 |
Adam Stevens |
Princeton University |
2 |
| #50 |
Yogesh Raghuvanshi |
Bank of America |
2 |
| #50 |
Nanjing Zhang |
Ptc Therapeutics |
2 |
| #50 |
Adam Wolf |
John Deere |
2 |
| #50 |
Changxia Yuan |
Bristol-Myers Squibb |
2 |
| #50 |
Peng Yuan |
Shanghai Jiao Tong University |
2 |
| #50 |
Dayong Zhai |
Turning Point Therapeutics |
2 |
| #50 |
Ming Lei |
Novartis Ag |
2 |
| #50 |
Brad Corrodi |
Stoneridge Electronics Ab |
2 |
| #50 |
Ryan M. Moslin |
Bristol-Myers Squibb |
2 |
| #50 |
Ryan Donovan |
Church & Dwight Co. |
2 |
| #50 |
LaTonya Kilpatrick-Liverman |
Colgate-Palmolive |
2 |
| #50 |
Mark Zhandry |
Ntt Research |
2 |
| #50 |
Stephen Anderson |
Rutgers, The State University Of New Jersey |
2 |
| #50 |
Arijit Ray |
Sri International |
2 |
| #50 |
Jianming Bao |
Merck |
2 |
| #50 |
Ajay Singh |
Slayback Pharma |
2 |
| #50 |
Laurence Du-Thumm |
Colgate-Palmolive |
2 |
| #50 |
Yaowen Li |
Ofs Fitel |
2 |
| #50 |
Elena Dotsenko |
Verizon |
2 |
| #94 |
Brian Teixeira |
Siemens Healthcare Limited |
1 |
| #94 |
Seung Hwan Baek |
Samsung |
1 |
| #94 |
Wei Deng |
Turning Point Therapeutics |
1 |
| #94 |
Joshua D. Rabinowitz |
Alexza Pharmaceuticals |
1 |
| #94 |
Caleb Levy |
Intertrust Technologies |
1 |
| #94 |
Kaushik Sengupta |
Caltech |
1 |
| #94 |
Tom W. Muir |
Princeton University |
1 |